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INTRODUCTION
As part of an endeavor to elucidate the mechanisms underlying the process of phagocytosis, our laboratories have studied the opsonic recognition of several bacterial species, including Staphylococcus aureus, by human peripheral blood phagocytes, i.e., the polymorphonuclear leukocytes (PMN)l and monocytes (MN) (1) (2) (3) . Results of these studies and those of other investigators (4-6) have indicated that, although the requirement for opsonic factors may differ among strains of staphylococci, significant phagocytosis and killing of these bacteria will not occur in the complete absence of serum opsonins. Major staphylococcal opsonins are a fragment of the third component of complement (C3b) and IgG class of antibodies. The peptidoglycan component of the staphylococcal cell wall has been proposed to be the key bacterial structure that interacts with these opsonins (7, 8) .
In an attempt to define the opsonic requirements for bacterial phagocytosis by extravascular phagocytes, we have recently studied the interactions between staphylococci and human alveolar macrophages (AM) (9, 10) . These studies led to the surprising observation that AM were able to ingest and kill a strain of S. aureus (502A) in the absence of opsonins. The goal of the present investigation was to determine the basis of this phenomenon. A total of 23 selected staphylococcal strains with major differences in cell wall composition were studied. We have found that protein A is the cell wall component of staphylococci that is recognized by AM, and discovered that human AM possess cytophilic IgG antibodies. Nonopsonic phagocytosis appears to result from the binding of protein A to the Fc portion of the IgG molecules on the surface of AM.
METHODS
Bacterial strains and cultural conditions. Previously described laboratory strains of S. aureus were 502A, Ev, Cowan I, EMS (an induced protein A-deficient mutant of Cowan I provided by A. Forsgren, Malmo University, Malmo, Sweden), Wood 46 (a noninduced protein A-poor strain), H HSmR (a spontaneous streptomycin-resistant mutant of strain H), 52A5 (a teichoic acid-deficient mutant of HSmR, both provided by J. T. Park, Tufts University, Boston, Mass.), and the encapsulated M and Smith strains with their respective nonencapsulated variant strains (Smith compact and M variant), kindly provided by A. Melly, Vanderbilt University, Nashville, Tenn. (1, 7, 8, 11) . Another related pair of S. aureus strains, one of which was coagulase-and clumping factor-negative, was kindly donated by C. P. A. Van Boven (University of Limburg, Maastricht, the Netherlands). In addition, six strains of S. aureus and three strains of Staphylococcus epidermidis were fresh clinical isolates from the blood of bacteremic patients. Escherichia coli ON2 (serotype 022:H16) is a serum resistant strain provided by B. Bjorksten (University of Umea, Umea, Sweden) (12) . All strains were maintained on blood agar plates at 4°C.
For each experiment bacteria were grown in Mueller Hinton broth (Difco Laboratories, Detroit, Mich.) in a 37°C shaking incubator for 18 h, washed three times with phosphate-buffered saline (PBS) pH 7.4, and resuspended in PBS to a concentration of 5 X 10' microorganisms/ml. For phagocytosis studies, the bacteria were radiolabeled by inoculating into 10 ml Mueller Hinton broth containing 20 MCi of [2,8-3H] adenine (sp act 34 Ci/mM, ICN Corporation, Irving, Calif.), as previously described (7) .
Isolation of phagocytic cells. PMN and MN were recovered from venous donor blood drawn into heparinized syringes (10 U heparin/ml blood) using a method modified from Boyum (13) as described previously (7) . The final PMN pellets were resuspended to a concentration of 5 X 106 PMN/ ml in Hanks' balanced salt solution (HBSS) containing 0.1% gelatin (GHBSS). Purity was evaluated by Wright's stained smears and viability by trypan blue exclusion; both exceeded 95%.
The MN containing mononuclear cell layer was washed three times with GHBSS, and total and differential counts were performed. The percentage of MN in these preparations varied between 25 and 45% with the remainder of the cell population being primarily lymphocytes. The suspensions were adjusted to contain 5 X 106 MN/ml in GHBSS. MN viability was always >95%. In some experiments MN were further purified using a slight modification of the method of Ackerman and Douglas (9, 14) using microexudate-coated surfaces. MN purity in these suspensions was always >95% and viability was 290%.
AM were obtained from normal donors by subsegmental saline lavage of the lingula of the left lung, or the middle lobe of the right lung, as previously described (15) . AM were obtained from smokers and nonsmokers. AM in the recovered lavage fluid were washed three times with GHBSS and resuspended at a concentration of 5 X 106 AM/ml GHBSS. Purity of AM suspensions was >85% (remaining cells were primarily lymphocytes) and viability exceeded 94% in all cases. The cell-free lavage fluids were routinely concentrated 150-fold by positive pressure ultrafiltration through a PM 10 membrane (Amicon Corp., Scientific Sys. Div., Lexington, Mass.) and stored at -70°C until use.
To study tissue macrophages from another site of the human body, about 2.5 liters of peritoneal dialysate was obtained from four clinically stable patients on chronic peritoneal dialysis for renal failure. None For some experiments AM were also obtained from 2-2.5-kg wild rabbits, 275-325-g Sprague-Dawley rats, and from 100-g Syrian golden hamsters by a standard lung lavage technique using sterile saline (16) . Each of the suspensions contained 295% AM, and AM viability was .90%.
Opsonins and opsonization procedure. Serum from 10 healthy donors was pooled and stored in 1-ml portions at -70°C. Just before use, serum was thawed and diluted to 10% in GHBSS. 100 ,ul of the bacterial suspension (-5 X 107 microorganisms) was mixed with 0.9 ml of 10% serum or with 0.9 ml GHBSS, and incubated for 30 min at 370C. The suspension was then designated opsonized (10% serum) or nonopsonized (GHBSS) bacteria, and held at 4°C until use. Heat-aggregated human IgG (agg-IgG, 10 mg/ml) was a gift of Dr. F. G. Cosio (Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis).
Phagocytosis assay. The uptake of opsonized and nonopsonized bacteria by phagocytes was determined using radiolabeled bacteria in an assay that has been described in detail previously (2, 8) . Briefly, 100 ul of the opsonized or nonopsonized bacterial suspension was mixed with 100 ,l of either PMN, MN, or AM in polypropylene vials (Bio-vials, Beckman Instruments Inc., Fullerton, Calif.), and phagocytosis was allowed to proceed for indicated times in a 37°C shaking incubator. The final bacteria to phagocyte ratio was -10:1. Phagocytosis was interrupted by adding 3-ml icecold PBS to the mixture. Nonphagocyte-associated bacteria were removed by three cycles of differential centrifugation (5 min, 160g, 4°C) and the phagocyte-associated radioactivity in the final pellets was determined by liquid scintillation counting as described (9) . Phagocytosis was expressed as a percent uptake of total added radioactivity, determined in a separate vial (2) .
Measurement of superoxide anion (O°) production. Release of O2 by AM was measured by the cytochrome c reduction method (17) . 1 (16) . Parallel tubes contained AM without bacteria ("resting" AM), bacteria without AM, and GHBSS alone.
Quantitation of staphylococcal protein A. The amount of protein A present on the surface of intact staphylococci was measured using the ability of protein A to agglutinate antibody-coated erythrocytes (18) . A 1% suspension of sheep erythrocytes (SRBC) was sensitized with a subagglutinating dose of rabbit IgG antibody to SRBC (N. L. Cappel Laboratories, Inc., Cochranville, Pa.), washed, and 0.1 ml was aliquoted into V-shaped wells of Cooke microtiter trays (Dynatech Laboratories, Inc., Alexandria, Va.). 100 ul of serial twofold dilutions of the bacterial suspension (1 X 10' microorganisms/ml) were added to the wells, thoroughly mixed with the sensitized SRBC, and incubated for 4 h at 37°C. The hemagglutinating titer of each strain was read as the highest dilution of the bacterial suspension that gave visible agglutination. Bacterial hemagglutinating titers were compared to the hemagglutinating titer of a simultaneously run solution containing 5 gg/ml of purified protein A (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.). This allowed for the amount of protein of each strain to be expressed as picograms of protein A/I X 106 cocci. The results are based on duplicate tests performed on 3 separate d; day-to-day variation in hemagglutinating titers never exceeded one twofold dilution step. Appropriate controls were bacteria incubated with nonsensitized SRBC, and sensitized SRBC incubated with PBS alone. The suspensions were in PBS.
"Sepharose-rosette" assay. The ability of PMN, MN, and AM to form rosettes around beads of Sepharose® CL-4B with covalently linked protein A residues (Pharmacia Fine Chemicals) was determined by incubating 0.5 ml of the phagocyte suspension with 0.1 ml beads (packed volume) for 30 min at 37°C with intermittent agitation. The preswollen Sepharose was allowed to equilibrate with GHBSS before use. After incubation, an equal volume of methylene blue (0.1%) was added and samples were sealed under cover slips on clean microscope slides. Rosetting (19) . Briefly, 1 X 106 cells in PBS containing 2% fetal calf serum and 15 mg/100 ml sodium azide were mixed with 2 vol of fluorescein isothiocyanate-conjugated (FITC) antibodies, polyvalent or monospecific for the major heavy-chain classes (a, y, ,u). FITC Pretreatment of PMN. For some studies PMN (5 X 106/ ml) were incubated with 1 mg agg-IgG/ml or with concentrated lung lavage fluid for 2.5 h at 4°C. After incubation these cells were washed twice with cold GHBSS and used immediately.
Statistical analysis. Standard error was used as an estimate of variance and statistical significance was assessed using the Student's t test for paired observations. The Pearson product-moment correlation coefficient (r) was used to measure linear correlations between two variables (20) .
RESULTS
Phagocytosis of clinical isolates of S. aureus. To extend our previous observation on the nonopsonic uptake of a laboratory strain of S. aureus by AM (9) , initial experiments in this study were performed with freshly isolated clinical strains. The kinetics of phagoMacrophage Cytophilic IgG-mediated Phagocytosis cytosis of four such S. aureus strains by PMN, MN, and AM is given in Fig. 1 . Phagocytosis was determined after 5-, 15-, and 60-min incubation, and opsonized as well as nonopsonized staphylococci were used. Opsonized bacteria were recognized and readily taken up by all three types of phagocytic cells with 40-60% of the staphylococci being phagocytized after 5-min incubation.
The capacity of AM to phagocytize S. aureus in the absence of opsonins was confirmed with three of the four clinical isolates. Although the rate of uptake of these three nonopsonized bacteria was slower than that of opsonized bacteria, 75-80% were AM-associated after 60-min incubation. One strain was not well recognized by AM in the absence of opsonins (30% uptake after 60 min, Fig. 1 ). In contrast to AM, PMN, and MN phagocytosis of nonopsonized S. aureus was <5 and 20%, respectively (Fig. 1 ). MN were somewhat better than PMN in recognizing nonopsonized staphylococci, and, interestingly, MN showed the poorest uptake of the one strain that was also relatively poorly taken up by AM (Fig. 1) (Fig. 4) . Rosetting of MN around protein A-Sepharose occurred much less frequently, and was virtually absent with PMN (Fig. 4) and neither cell rosetted around Sepharose without protein A (not shown in Fig.   4 ): The percentage of protein A-coated beads that had three or more phagocytes attached was <6% for PMN, 25 -35% for MN, and >90% for AM. In addition, beads positive for AM rosettes regularly had >10 AM attached and AM-induced "bridging", i.e., agglutination, of beads occurred (Fig. 4) and with FITC-protein A, but were negative with aor ,u-chain specific conjugates (Fig. 5) . AM from smokers and nonsmokers were found to have surface IgG. In addition to surface IgG, smoker AM also contained variable amounts of yellow autofluorescent material that seemed to be localized within cytoplasmic granules or vacuoles. Smoker AM autofluorescence has been reported before (22) . MN were weakly positive for surface IgG, and PMN did not show any fluorescence with the antisera used (data not shown). These findings FIGURE 5 Plasma membrane-associated fluorescence and size of nonsmoker AM.
demonstrate that, in contrast to blood PMN and MN, AM carry appreciable amounts of membrane-bound IgG that may be involved in protein A-mediated uptake of staphylococci.
Inhibition of AM phagocytosis. Treatment of AM with trypsin or pronase for 30 min had little effect on the ability of AM to phagocytize nonopsonized S. aureus Cowan I, but greatly inhibited the uptake of opsonized bacteria (Table II) . Neuraminidase (30 min) had little or no effect on the uptake of either opsonized IgG on AM of a nonsmoker. Note uniform surface Macrophage Cytophilic IgG-mediated Phagocytosis 69 or nonopsonized staphylococci. It was additionally found that treatment of AM with trypsin, pronase, or papain for 30 min did not result in extensive loss of AM surface IgG; focal loss of the dense fluorescent "coat" of some AM was noted, resulting in a "stippled" appearance of these cells (data not shown). However, when incubation of AM with each of these three enzymes was extended to 2 h, virtually all surface IgG was removed.
Opsonization of protein A-rich strains with 10% normal serum greatly reduced their ability to agglutinate sensitized SRBC. The agglutination titers of four protein A-rich strains, including S. aureus Cowan I, were decreased by 84-97% after opsonization in 10% serum. Taken together, these findings indicate that opsonization of S. aureus masks cell surface protein A residues, and that these bacteria are taken up by AM via a trypsin-and pronase-sensitive receptor mechanism. The uptake of nonopsonized S. aureus, however, depends on protein A and is mediated through trypsinand pronase-insensitive receptors of AM, and may involve surface IgG.
To further define the role of surface IgG in phagocytosis, AM were pretreated with soluble purified protein A or with F(ab')2 fragments specific for the Fc part of IgG (anti-Fc). The uptake of opsonized S. aureus Cowan I was little affected by protein A or antiFc treatment of AM, but the uptake of nonopsonized staphylococci was inhibited (Table III) . This observation lends further support to the hypothesis that opsonized and nonopsonized S. aureus are phagocytized via distinct AM receptor mechanisms, and that the receptor for nonopsonized staphylococci is AM surface IgG.
Nature of AM surface IgG. The AM surface IgG was of a different nature than the IgG found on the surface of PMN pretreated with agg-IgG. The aggIgG-treated PMN had a granular, speckled appearance when stained with FITC-protein A unlike the diffuse and uniform staining of the AM surface shown in Fig.  5 . Also, when PMN with attached agg-IgG were incubated at 37°C they cleared all their surface IgG within 2 h, in contrast to AM that retained their surface IgG over this period of incubation (Table IV) . Furthermore, agg-IgG-treated PMN remained unable to phagocytize nonopsonized S. aureus Cowan I (Table  IV) . PMN incubated with concentrated lung lavage fluid (containing 1 mg IgG/ml) did not become positive for surface immunoglobulins by immunofluorescence and, as with agg-IgG treatment, remained unable to phagocytize nonopsonized S. aureus Cowan I (Table IV) .
Taken together, these results indicate that normal human lung lavage fluids do not contain appreciable quantities of aggregated or immune-complexed IgG, and that the surface IgG on AM is also not aggregated or immune-complexed.
Phagocytosis by human peritoneal macrophages and by AM Because phagocytosis of staphylococci by AM has been studied in vitro and in vivo in other animal species, phagocytosis by AM from humans, rabbits, rats, and hamsters was compared. In six separate experiments, the mean (range) percent uptake of nonopsonized S. aureus Cowan I was 80 (65-88)% for human AM, 18 (10-30)% for rabbit AM, 11 (7) (8) (9) (10) (11) (12) (13) (14) % for rat AM, and 26 (17-34)% for hamster AM. In comparison with Cowan I, the uptake of the protein A-negative mutant strain EMS was strikingly lower for human AM (11 [5-141%) , but was also significantly lower for AM of the other animal species.
DISCUSSION
The main goal of this investigation was to elucidate the mechanism of phagocytosis of nonopsonized staphylococci by human AM. We found that phagocytosis of nonopsonized staphylococci by these phagocytes only occurs with protein A-positive strains, and that the efficiency of uptake depends on the amount of protein A on the bacterial surface.
A likely explanation for the protein A receptor mechanism of human AM was found by demonstrating the presence of surface IgG antibodies on these cells. (32) (33) (34) (35) .
In this study we did not determine the subclass(es) of IgG that are present on human AM, and no data is available on the subclass specificities of the IgG receptor of AM (43) (44) (45) . Interestingly, injury to human platelets by S. aureus has recently been shown also to involve interactions of cell wall protein A, IgG, and platelet Fc receptors (46) .
The observed increases in AM hexose monophosphate shunt activity and superoxide anion production induced by nonopsonized S. aureus do not differ significantly from previously reported AM responses to opsonized staphylococci (16, 17) . Although it is not known how these responses are triggered, the binding of protein A to IgG has been shown to result in significant conformational changes in the Fc fragment, which may provide the initial stimulus for the metabolic burst (47) .
Our experiments indicated that the AM surface IgG are not in an aggregated or immune-complexed state. The uniform and diffuse staining of the AM surface, the persistence of the AM surface IgG upon prolonged incubation at 37°C, and the ability of the surface IgG to mediate ingestion of bacteria contrast with our results and those of other investigators (48) (49) (50) (51) that have studied the interactions between aggregated or immune-complexed antibodies with phagocytic cells. The IgG found on normal human AM more likely fits the category of so called cytophilic immunoglobulins (52, 39) .
The role in host defense of cytophilic antibodies on human AM, and on its precursor cell, the circulating MN (53) , is currently completely unknown. Smoker AM were found to contain large amounts of autofluorescent cytoplasmic inclusions as has been noted by others (22) , and one possibility might be that these inclusions represent antigenic material that has been cleared via specific cytophilic antibody. Previous studies suggested that protein A inhibits opsonization for phagocytosis by PMN (54, 55) . Paradoxically, protein A was found in this study to promote phagocytosis of nonopsonized staphylococci by human AM, and this may be important in local immunity of the human lung. Also, some strains of group A and the majority of strains of group C and G streptococci carry an Fc binding structure analogous to protein A (56) . These strains may thus also be phagocytized via cytophilic IgG.
Our findings with human peritoneal macrophages, although obtained from patients, suggest that cytophilic IgG-mediated phagocytosis may be a characteristic that is common to human tissue macrophages. The inefficiency of AM from rabbits, rats, and hamsters to phagocytize nonopsonized staphylococci is in 72 Verbrugh, Hoidal, Nguyen, Verhoef, Quie, and Peterson agreement with previous work using these animal species (57) (58) (59) (60) . These species' differences point out that functions of human macrophages cannot be directly inferred from studies using macrophages from other animals.
